| 637 Weekly
contraceptive patch launched A transdermal contraceptive patch
(Evra) is launched this week by Janssen-Cilag ...[more]
637 Call for reducing the availability of co-proxamol to help prevent high
number of drug-related suicides A call has been made by the Centre for Suicide Research,
Oxford, to reduce the availability of co-proxamol. It suggests this could include more careful
prescribing and better disposal of unwanted supplies...[more]
638 Back to the
pharmacy for defeated Assembly man? Geraint
Davies, the only pharmacist in the National Assembly for Wales, lost
his Rhondda seat at the Assembly election on 1 May...[more]
638 Contract regulation changes to be made Confirmation that
controls over new National Health Service pharmacy contracts in England will be relaxed has been
given in the House of Lords...[more]
638 Digital changes delay BNF 45 publication The latest edition
of the British National Formulary (BNF 45, March 2003) has now been published. It was delayed
by changes to the database that underpins the BNF and which will allow digital versions to be
created...[more]
638 Concern as Ireland's drugs are "re-exported to the UK for profit" Pharmacists
in the Republic of Ireland are worried about shortages of medicines caused by parallel imports
to Britain...[more]
638 OTC statins will depend on safety profile Patient safety
is the prime consideration in any decision to make statins available over the counter, public
health minister Hazel Blears said this week...[more]
639 Boots gets
its new chief executive from Asda The Boots Co
Plc has appointed Richard Baker as its new chief executive...[more]
639 Boots fined £15,000 after worker is injured Boots The Chemists has been fined more than £15,000 after pleading guilty to breaches of safety regulations at its Petty Cury branch in Cambridge that led to one member of staff being injured by a unit she was trying to move...[more]
639 NPA fights pharmacy's corner in out-of-hours service planning The
National Pharmaceutical Association, has been trying to convince the Department of Health that
patients deserve proper pharmaceutical services outside of normal working hours...[more]
639 New contract
roadshow...[more]
639 Scottish
training link with CPP...[more]
639 PGD guidance
issued...[more]
639 Moss sexual
health leaflet...[more]
639 Technician
job profile withdrawn...[more]
639 Medicines
aid for Iraq...[more] |
640 ABPI
launches clinical trials register on the web An online register
of industry-sponsored clinical trials was launched earlier this week by
the Association of the British Pharmaceutical Industry...[more]
640 Over 1,000
patients still waiting for drug assessments, says MS charity More
than 1,000 people with multiple sclerosis are still waiting to see if
they will qualify for treatment under the Department of Health's risk-sharing
scheme for disease-modifying drugs, according to the Multiple Sclerosis
Society...[more]
640 Warning on
use of infrared thermometers Special advice should be given
to people using infrared ear thermometers, the Medicines and Healthcare
products Regulatory Agency has recommended...[more]
641 "Prescribe-a-chat" website
wins award An internet discussion group and website for prescribing
advisers in the Highland region of Scotland, known as "Prescribe-a-chat",
won a Guild of Healthcare Pharmacists information technology award sponsored
by First DataBank Europe...[more]
641 Foundation
trusts will distort the NHS Foundation trusts will alter the
distribution of hospital services to the detriment of areas where foundation
status takes longer to achieve...[more]
641 Funding available
for PCT-based supplementary prescribing projects The National
Primary and Care Trust Development Programme (NatPaCT) is looking for
primary care trusts to undertake developmental projects...[more]
Research & Development
642 Asthma
vaccine possible in six years A
vaccine for people with allergies has shown promising results and may lead
to the development of a treatment for asthma...[more]
642 Novel agent decreases interleukin-2 toxicity A
new class of drug decreases a major toxic effect of a promising anticancer
agent and appears to increase its anti-tumour activity...[more]
642 Benefits of fusion inhibitor against HIV maintained
at 48 weeks Data for the first HIV fusion inhibitor, enfuvirtide
(Fuzeon), for HIV/AIDS shows that benefits achieved at 24 weeks have
been maintained at 48 weeks...[more]
642 Enzyme structure may lead to new anti-malaria
drugs Publication of the structure of an enzyme produced
by the malaria parasite may allow the development of new antifolate drugs
to which there may be less resistance than there is to existing medicines...[more] |
